Thomas Hach
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
-
- Diabetes Treatment and Management 14
- Diabetes Management and Research 2
-
- Metabolism, Diabetes, and Cancer 8
- Sphingolipid Metabolism and Signaling 3
- Co-authors
- Ele Ferrannini (3 shared papers)Stefan Hantel (5 shared papers)Sabine Pinnetti (2 shared papers)Susanne Crowe (3 shared papers)Giulia Ferrannini (1 shared paper)Arjun Sanghvi (1 shared paper)Kevin D. Hall (1 shared paper)Uli C. Broedl (7 shared papers)
- Journals
- Neurology (5 papers)Diabetes Obesity and Metabolism (3 papers)Journal of Hypertension (3 papers)Neurology Neuroimmunology & Neuroinflammation (3 papers)Circulation (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Hach
38 papers receiving 1.2k citations
Thomas Hach's Hit Papers
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 766
- Nephrology 97
- Pharmacology 128
- Pathology and Forensic Medicine 124
- Surgery 272
Countries citing papers authored by Thomas Hach
This map shows the geographic impact of Thomas Hach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hach more than expected).
Fields of papers citing papers by Thomas Hach
This network shows the impact of papers produced by Thomas Hach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hach. The network helps show where Thomas Hach may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Hach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 285 | |
| 2 | 2013 | 187 | |
| 3 | 2013 | 185 | |
| 4 | 2015 | 97 | |
| 5 | Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy Hit paper breakdown → | 2024 | 72 |
| 6 | 2013 | 46 | |
| 7 | 2014 | 38 | |
| 8 | 2022 | 37 | |
| 9 | 2020 | 36 | |
| 10 | 2008 | 28 | |
| 11 | 2021 | 25 | |
| 12 | 2022 | 25 | |
| 13 | 2014 | 19 | |
| 14 | 2016 | 18 | |
| 15 | 2022 | 17 | |
| 16 | 2018 | 14 | |
| 17 | 2022 | 13 | |
| 18 | 2021 | 9 | |
| 19 | 2009 | 9 | |
| 20 | 2005 | 8 |
About Thomas Hach
Thomas Hach is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Nephrology and Pathology and Forensic Medicine, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (8 papers), Renal Diseases and Glomerulopathies (5 papers), Multiple Sclerosis Research Studies (5 papers), Pancreatic function and diabetes (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Diabetes Management and Research (2 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (766 citations), Nephrology (97 citations), Pharmacology (128 citations), Pathology and Forensic Medicine (124 citations) and Surgery (272 citations). Thomas Hach has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ele Ferrannini, Stefan Hantel, Sabine Pinnetti, Susanne Crowe, Giulia Ferrannini, Arjun Sanghvi, Kevin D. Hall, Uli C. Broedl, Hans J. Woerle and H.J. Woerle. Their work appears in journals such as Neurology, Diabetes Obesity and Metabolism, Journal of Hypertension, Neurology Neuroimmunology & Neuroinflammation and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.